These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8495024)
1. Resistant tuberculosis: successful treatment with amikacin, ofloxacin, clofazimine, and pas. Shah A; Bhagat R; Panchal N Tuber Lung Dis; 1993 Feb; 74(1):64-5. PubMed ID: 8495024 [No Abstract] [Full Text] [Related]
2. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism]. Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388 [TBL] [Abstract][Full Text] [Related]
3. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar]. Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814 [TBL] [Abstract][Full Text] [Related]
4. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin]. Krasucka-Kluźniak A; Krakówka P Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906 [TBL] [Abstract][Full Text] [Related]
5. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Tabarsi P; Chitsaz E; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Amiri M; Mansouri D; Masjedi MR; Velayati AA; Caminero JA Microb Drug Resist; 2010 Mar; 16(1):81-6. PubMed ID: 20192820 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand. McNaughton A; Blackmore T; McNaughton H Eur Respir J; 2016 Oct; 48(4):1256-1259. PubMed ID: 27694421 [No Abstract] [Full Text] [Related]
10. [Therapeutic effect of ofloxacin on 'treatment-failure' pulmonary tuberculosis]. Tsunekawa H; Miyachi T; Nakamura E; Tsukamura M; Amano H Kekkaku; 1987 Sep; 62(9):435-9. PubMed ID: 3480971 [No Abstract] [Full Text] [Related]
11. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients]. Ye Z; Pei X; Yang Y Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811 [TBL] [Abstract][Full Text] [Related]
12. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council. Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349 [TBL] [Abstract][Full Text] [Related]
14. Extensively drug resistance (XDR) tb is not always fatal. Jain NK; Agnihotri SP; Sharma KK; Gupta S; Gupta P Indian J Tuberc; 2009 Jan; 56(1):48-50. PubMed ID: 19402272 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of tuberculosis. Harris AA; Karakusis P Prim Care; 1979 Mar; 6(1):43-62. PubMed ID: 111269 [No Abstract] [Full Text] [Related]
16. [Comparative evaluation of different regimens of chemotherapy of pulmonary tuberculosis in middle-aged and old patients]. Kordzakhiia TP Probl Tuberk; 1976 Nov; (11):30-3. PubMed ID: 1019124 [No Abstract] [Full Text] [Related]
18. Ethambutol in the re-treatment of multi-resistant advanced pulmonary tuberculosis (salvage cases). Roy DC; Sen PC; Bajpai BK Indian J Chest Dis; 1974 Jul; 16(3):153-62. PubMed ID: 4422083 [No Abstract] [Full Text] [Related]
19. Difficulties in the diagnosis and treatment of drug-resistant tuberculosis and tuberculous empyema. Glisson J; Mehta JB J Tenn Med Assoc; 1992 Sep; 85(9):419-22. PubMed ID: 1405623 [No Abstract] [Full Text] [Related]
20. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis. Chierakul N; Klomsawat D; Chulavatnatol S; Chindavijak B Int J Tuberc Lung Dis; 2001 Mar; 5(3):278-82. PubMed ID: 11326828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]